An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|3|273-286

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.3, 2006-01, pp. : 273-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of 12 Ca 2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression

By Takara K.   Sakaeda T.   Tanigawara Y.   Nishiguchi K.   Ohmoto N.   Horinouchi M.   Komada F.   Ohnishi N.   Yokoyama T.   Okumura K.  

European Journal of Pharmaceutical Sciences, Vol. 16, Iss. 3, 2002-08 ,pp. : 159-165

Elsevier

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite

Multidrug resistance (MDR) in cancer - Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

By Krishna R.   Mayer L.D.  

European Journal of Pharmaceutical Sciences, Vol. 11, Iss. 4, 2000-10 ,pp. : 265-283

Elsevier

Access to resources Recommend Favorite

MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion

By Lööscher Wolfgang   Delanty Norman  

Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. : 711-713

Future Medicine

Access to resources Recommend Favorite

Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 4, 2011-04 ,pp. : 570-594

Bentham Science Publishers

Access to resources Recommend Favorite